β-Amyloid (10-35), amide is composed of 26 aa (10-35 residues of the Aβ peptide) and is the primary component of the amyloid plaques of Alzheimer's disease.
β-Amyloid (10-35), amide is a synthetic peptide fragment corresponding to residues 10 through 35 of the amyloid beta (Aβ) peptide, with an amidated C-terminus. This peptide encompasses a core region critical for the aggregation and fibril formation characteristic of amyloid plaques observed in neurodegenerative disorders. Its sequence and chemical modifications make it a widely utilized model for studying the physicochemical properties, aggregation kinetics, and structural transitions of amyloidogenic peptides. As such, β-Amyloid (10-35), amide holds significant value in elucidating the molecular mechanisms underlying protein misfolding and aggregation, as well as in the development of analytical and screening methodologies for amyloid research.
Aggregation studies: Researchers frequently employ β-Amyloid (10-35), amide in the investigation of peptide self-assembly and amyloid fibrillogenesis. The peptide's propensity to form β-sheet-rich aggregates mirrors the behavior of full-length amyloid beta, enabling detailed kinetic and morphological analyses of fibril formation. These studies provide fundamental insights into the nucleation and elongation phases of amyloid aggregation, supporting the development of theoretical models and experimental systems for understanding protein misfolding diseases.
Structural biology: The defined sequence and aggregation characteristics of this peptide fragment make it an excellent substrate for structural studies using techniques such as nuclear magnetic resonance (NMR), circular dichroism (CD) spectroscopy, and X-ray diffraction. By probing the conformational transitions and secondary structure elements adopted during aggregation, scientists gain valuable information on the molecular architecture of amyloid fibrils. Such data are critical for mapping aggregation-prone regions and elucidating the structural determinants of peptide assembly.
Screening of aggregation modulators: β-Amyloid (10-35), amide serves as an effective tool in high-throughput screening assays aimed at identifying small molecules, peptides, or other agents capable of modulating amyloid aggregation. The reproducible aggregation behavior of this fragment allows for quantitative assessment of compound efficacy in inhibiting or altering fibril formation. These screening assays are instrumental in early-stage research focused on the discovery of aggregation inhibitors, molecular chaperones, or other modulatory agents.
Biophysical method development: The peptide's well-characterized aggregation profile renders it a standard model for the development and validation of biophysical and analytical techniques. Methods such as fluorescence spectroscopy, electron microscopy, atomic force microscopy, and dynamic light scattering often utilize this peptide to optimize protocols for detecting, quantifying, and characterizing amyloid structures. Its use in method development ensures the reliability and reproducibility of analytical approaches in amyloid research.
Material science research: Beyond its role in neurodegenerative disease modeling, β-Amyloid (10-35), amide has found application in the field of biomaterials. Its ability to self-assemble into ordered nanostructures is harnessed to explore peptide-based nanomaterials, hydrogels, and scaffolds. These studies contribute to the broader understanding of peptide-driven self-assembly and offer potential strategies for designing novel biomimetic materials with defined mechanical and functional properties.
Through these diverse applications, β-Amyloid (10-35), amide provides a robust and versatile platform for advancing research into amyloidogenesis, protein aggregation, and peptide-based materials, supporting both fundamental investigations and the development of innovative analytical tools.
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More